Gábor Mikala (Gabor Mikala)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Endoplasmic Reticulum Stress

Multiple Myeloma

Chronic Lymphocytic Leukemia

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

András Bors, András Kozma, Ágnes Tomán, Zoltán Őrfi, Nóra Kondor, Szabolcs Tasnády, István Vályi-Nagy, Péter Reményi, Gábor Mikala, Hajnalka Andrikovics
IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma. Cancers 16 (2) (2024)
András Bors, András Kozma, Ágnes Tomán, Zoltán Őrfi, Nóra Kondor, Szabolcs Tasnády, István Vályi-Nagy, Péter Reményi, Gábor Mikala, Hajnalka Andrikovics
IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma. Cancers 16 (2) (2024)
Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe, Keith E Stockerl-Goldstein, Sarah M Larson, Illes Arpad, Giulio A Milone, Massimo Martino, Patrick Joseph Stiff, Douglas Sborov, Denise Pereira, Ivana Micallef, Gemma Moreno-Jiménez, Gábor Mikala, Maria Liz Paciello Coronel, Udo Holtick, John Hiemenz, Muzaffar H Qazilbash, Nancy Hardy, Tahir Latif, Irene García-Cadenas, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Inbal Goldstein, Debby Ickowicz, Liron Shemesh-Darvish, Shaul Kadosh, Feng Gao, Mark G Frattini, Ravi Vij, John F Dipersio
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. Nature medicine (2023)
Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International journal of molecular sciences 24 (6) (2023)
Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International journal of molecular sciences 24 (6) (2023)
Irit Avivi, David H Vesole, Julio Dávila-Valls, Lidia Usnarska-Zubkiewicz, Magdalena Olszewska-Szopa, Vibor Milunović, Bartłomiej Baumert, Bogumiła Osękowska, Anna Kopińska, Massimo Gentile, Borja Puertas-Martinez, Paweł Robak, Edvan de Queiroz Crusoé, Luis-Gerardo Rodríguez-Lobato, Małgorzata Gajewska, Gergely Varga, Michel Delforge, Yael Cohen, Alessandro Gozzetti, Camila Peña, Chaim Shustik, Gábor Mikala, Klara Zalac, H Denis Alexander, Peter Barth, Katja Weisel, Joaquín Martínez-López, Anna Waszczuk-Gajda, Mateusz Krzystański, Artur Jurczyszyn
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients. Cancers 15 (17) (2023)
Zsolt Matula, Ferenc Uher, István Vályi-Nagy, Gábor Mikala
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. International journal of molecular sciences 24 (6) (2023)
Lili Kotmayer, Tamás László, Gábor Mikala, Richárd Kiss, Luca Lévay, Lajos László Hegyi, Stefánia Gróf, Tibor Nagy, Gábor Barna, Péter Farkas, Júlia Weisinger, Zsolt Nagy, Alexandra Balogh, Tamás Masszi, Judit Demeter, Adrienn Sulák, Zoltán Kohl, Hussain Alizadeh, Miklós Egyed, Piroska Pettendi, Lajos Gergely, Márk Plander, Zsolt Pauker, András Masszi, András Matolcsy, Róbert Szász, Csaba Bödör, Donát Alpár
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax. International journal of molecular sciences 24 (6) (2023)
Cecilia Czakó, Dóra Gerencsér, Kitti Kormányos, Klaudia Kéki-Kovács, Orsolya Németh, Gábor Tóth, Gábor László Sándor, Anita Csorba, Achim Langenbucher, Zoltán Zsolt Nagy, Gergely Varga, László Gopcsa, Gábor Mikala, Illés Kovács, Nóra Szentmáry
Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography. Journal of clinical medicine 12 (16) (2023)
Lili Kotmayer, Tamás László, Gábor Mikala, Richárd Kiss, Luca Lévay, Lajos László Hegyi, Stefánia Gróf, Tibor Nagy, Gábor Barna, Péter Farkas, Júlia Weisinger, Zsolt Nagy, Alexandra Balogh, Tamás Masszi, Judit Demeter, Adrienn Sulák, Zoltán Kohl, Hussain Alizadeh, Miklós Egyed, Piroska Pettendi, Lajos Gergely, Márk Plander, Zsolt Pauker, András Masszi, András Matolcsy, Róbert Szász, Csaba Bödör, Donát Alpár
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax. International journal of molecular sciences 24 (6) (2023)
Lili Kotmayer, Tamás László, Gábor Mikala, Richárd Kiss, Luca Lévay, Lajos László Hegyi, Stefánia Gróf, Tibor Nagy, Gábor Barna, Péter Farkas, Júlia Weisinger, Zsolt Nagy, Alexandra Balogh, Tamás Masszi, Judit Demeter, Adrienn Sulák, Zoltán Kohl, Hussain Alizadeh, Miklós Egyed, Piroska Pettendi, Lajos Gergely, Márk Plander, Zsolt Pauker, András Masszi, András Matolcsy, Róbert Szász, Csaba Bödör, Donát Alpár
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax. International journal of molecular sciences 24 (6) (2023)
Veronika S Urban, Andrea Cegledi, Gábor Mikala
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. GeroScience 45 (2) (2022)
Veronika S Urban, Andrea Cegledi, Gábor Mikala
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. GeroScience (2022)
Veronika S Urban, Andrea Cegledi, Gábor Mikala
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. GeroScience 45 (2) (2022)
Veronika S Urban, Andrea Cegledi, Gábor Mikala
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. GeroScience (2022)
Veronika S Urban, Andrea Cegledi, Gábor Mikala
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. GeroScience 45 (2) (2022)
Kitti Kormányos, Klaudia Kovács, Orsolya Németh, Gábor Tóth, Gábor László Sándor, Anita Csorba, Cecília Nóra Czakó, László Módis, Achim Langenbucher, Zoltán Zsolt Nagy, Gergely Varga, László Gopcsa, Gábor Mikala, Nóra Szentmáry
Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy-Analysis of 130 Eyes of 65 Subjects. Journal of clinical medicine 11 (7) (2022)
Veronika S Urban, Andrea Cegledi, Gábor Mikala
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. GeroScience 45 (2) (2022)
Nikolett Lupsa, Ákos Szegedi, András Gézsi, Zoltán Vuncs, Tamás Masszi, Gábor Mikala, Péter Reményi, Sara Deola, Arun Prasath Lakshmanan, Annalisa Terranegra, Edit Irén Buzás, Zoltán Pós
Decreased Plasma Level of Cytokeratin 20 (KRT20) Is Indicative of the Emergence and Severity of Acute GvHD Irrespective to the Type of Organ Involvement. Biomedicines 10 (3) (2022)
Kitti Kormányos, Klaudia Kovács, Orsolya Németh, Gábor Tóth, Gábor László Sándor, Anita Csorba, Cecília Nóra Czakó, Achim Langenbucher, Zsolt Zoltán Nagy, Gergely Varga, László Gopcsa, Gábor Mikala, Nóra Szentmáry
Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects. Journal of ophthalmology 2021 (2021)
Katalin Piroska Kiss, Gergely Varga, Gábor Mikala, Katalin Balassa, Andras Bors, Petra Kovy, Nora Meggyesi, Andras Kozma, Otto Csacsovszki, Peter Remenyi, Istvan Valyi-Nagy, Attila Tordai, Tamas Masszi, Hajnalka Andrikovics
The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma. Leukemia & lymphoma 59 (3) (2017)